Skip to content

Effect of Ayurveda Treatment in multiple joint pain

Efficacy of Ayurveda Intervention in Rheumatoid Arthritis (Amavata): A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098704
Enrollment
52
Registered
2025-12-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Sponsors

Dr Monika
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age: Between 20 and 60 years. 2. Sex: Both sexes. 3. Patients who meet ACR(American College of Rheumatology) Criteria. 4. Patients who are willing to give Informed Consent. 5. Patient fit for Virechana (Kosthashodhan).

Exclusion criteria

Exclusion criteria: 1.Chronicity more than 10 years. 2.Having any severe crippling deformity (Unable to walk without support, confined to wheel chair or bed). 3.Uncontrolled systemic illness like DM, HTN or Renal disorder. 4.Pregnant and lactating women. 5.Patient on any medication for Rheumatoid Arthritis since 4 weeks. 6.Intra-articular corticosteroid injection within 2 months.

Design outcomes

Primary

MeasureTime frame
Disease Activity Score 28 (CRP)Timepoint: Baseline,15th,30th,45th,60th Day.

Secondary

MeasureTime frame
1. American College of Rheumatology Remission & Response Criteria (ACR 20/50/70). 2.Disability Index The Indian Health Assessment Questionnaire (Indian version of Health Assessment Questionnaire (HAQ) and Disability Index (HAQ-DI). 3. Ayurveda Parameter based on NAMC EC-6. 4. CRP(C-reactive protein)Timepoint: Baseline,15th,30th,45th,60th Day.;1. CBC(Complete Blood Count),ESR(Erythrocyte Sedimentation Rate),RA Titre (Rheumatoid Factor). 2. Inflammatory Marker(IL-6).Timepoint: Baseline,60th Day.;Quality of life- Short Form Health Survey (SF-36).Timepoint: Baseline,30th,60th Day.

Countries

India

Contacts

Public ContactDr Basavaraj R Tubaki

KAHERs Shri BMK Ayurveda Mahavidyalaya Shahapur Belagavi

ayurbasavaraj@gmail.com9448634660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026